Salicylic Acid 3% Topical Ointment

Manufacturer
Syntenza Pharmaceuticals LLC
Effective date
2018-10-16
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 20:26:36

Label at a glance#

ProductSALICYLIC ACID
Active ingredientSALICYLIC ACID
Label structure14 sections

Indications and uses

An external treatment for the inflammation and irritation associated with many common forms of dermatitis, including certain eczematoid conditions. These conditions include complications associated with pyodermas. Indicated also in the treatment of insect bites, burns and fungal infections.

Dosage and administration

Patients should be advised to follow these step-by-step instructions for application of Salicylic Acid 3% topical ointment: Hands should be washed thoroughly. When using tubes, the tip of the tube should not come into contact with the area to be treated; the tube should be recapped tightly after each application. If applying with a cotton-tipped applicator, which is recommended, use once and discard. Salicylic Aci...

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Rx Only

Prescribing Information

DESCRIPTION

DESCRIPTION SECTION

Salicylic Acid 3% topical ointment contains 30 mg salicylic acid per gram in a base containing: PEG-8, PEG-75, Benzoic acid and Quercus Alba Bark Extract.

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

The mechanism of action of Salicylic Acid 3% topical ointment is not known. While the following animal data are available, their clinical significance is unknown. It has been demonstrated that Salicylic Acid 3% topical ointment significantly reduces methicillin-resistant Staphylococcus aureus (MRSA) protected by biofilms in wounds using porcine models. In addition, Salicylic Acid 3% topical ointment stimulates re-epithelialization of second-degree burns in porcine models.

CLINICAL STUDIES

CLINICAL STUDIES SECTION

A randomized, double-blind, placebo-controlled study evaluated the rate of wound re-epithelialization. Four partial-thickness wounds (2×2 cm & 0.2 mm deep) were created under local anesthesia on the thighs of 13 normal, healthy, male volunteers with an electrokeratome. Salicylic Acid 3% topical ointment substantially increased the rate of re-epithelialization by 63% over the vehicle alone (p<0.01) and 77% over untreated control (p<0.005).

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

An external treatment for the inflammation and irritation associated with many common forms of dermatitis, including certain eczematoid conditions. These conditions include complications associated with pyodermas. Indicated also in the treatment of insect bites, burns and fungal infections.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

Salicylic Acid 3% topical ointment is contraindicated for use in those patients who are hypersensitive to topical polyethylene glycols.

PRECAUTIONS

PRECAUTIONS SECTION

For external use only. Not to be used in eyes.

DRUG INTERACTIONS

DRUG INTERACTIONS SECTION

It is not known if Salicylic Acid 3% topical ointment interacts with other topical medications applied to the treatment area. The use of Salicylic Acid 3% topical ointment with other topical drugs has not been studied.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

Salicylic Acid 3% topical ointment is generally well tolerated and non-irritating. A small percentage of patients may experience a temporary burning sensation upon application of the ointment.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Patients should be advised to follow these step-by-step instructions for application of Salicylic Acid 3% topical ointment:

Hands should be washed thoroughly.

When using tubes, the tip of the tube should not come into contact with the area to be treated; the tube should be recapped tightly after each application.

If applying with a cotton-tipped applicator, which is recommended, use once and discard.

Salicylic Acid 3% topical ointment should be applied twice a day for best results.

Gently rinse the area to be treated with saline or water and then pat dry. Salicylic Acid 3% topical ointment can be applied directly to the wound or placed on dry gauze and then placed on the wound. Wet-Packs or Wet-To-Dry Dressings are not recommended since they will dilute the ointment and decrease its effectiveness. Salicylic Acid 3% topical ointment is designed to provide moisture to the wound.

Spread a generous quantity of Salicylic Acid 3% topical ointment evenly over the desired area to yield a thin continuous layer of approximately 1/8 of an inch of thickness. There may be a mild warming sensation, or slight burning, to the treated area for 3-5 minutes after application. If irritation occurs or symptoms persist after 10 days, discontinue use and consult your physician.

Try to keep the area being treated clean and exposed to air when possible. Apply an appropriate dressing to shield the area from clothes or exposure to water or dirt.

If there is no improvement in the wound within 7 days, consult your physician for further evaluation of the wound. If there is no response to the ointment at all, then the wound should be re-evaluated for other contributing factors to the wound healing process.

PEDIATRIC USE

PEDIATRIC USE SECTION

Safety and effectiveness in pediatric patients has not been established.

HOW SUPPLIED

HOW SUPPLIED SECTION

30 g tubeNDC 72056-030-01

STORAGE AND HANDLING SECTION

Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (between 59°F and 86°F). Brief exposure to temperatures up to 40°C (104°F) may be tolerated provided the mean kinetic temperature does not exceed 25°C (77°F); however, such exposure should be minimized.

SPL UNCLASSIFIED SECTION

Manufactured for:
Syntenza Pharmaceuticals LLC
Edina, MN 55436, USA

Rev. 06/18

PRINCIPAL DISPLAY PANEL - 28.4 g Tube Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

SYNTENZA

NDC 72056-030-01

Salicylic Acid 3% Topical Ointment

Net Wt. 1 oz. (28.4 g)

Rx Only

PRINCIPAL DISPLAY PANEL - 28.4 g Tube Carton
PRINCIPAL DISPLAY PANEL - 28.4 g Tube Carton

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
312888salicylic acid 3 % Topical OintmentPSN1
312888salicylic acid 0.03 MG/MG Topical OintmentSCD1
312888salicylic acid 3 % Topical OintmentSY1
312888salicylic acid 3 % Topical StickSY1

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
c6f86816-7da6-43ea-8c25-ac9758311cc5Product name120220118
252e11b6-1a9a-4283-a242-df2c129c496dProduct name320170717

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
72056-030-012020-01-31C16284748780-19d75b9d0-63a3-f424-e053-dadaa90a57ceSalicylic Acid 3% Topical Ointment

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
72056-030-01SALICYLIC ACID28.4 g in 1 TUBEOINTMENT28.41
72056-030-01SALICYLIC ACID1 in 1 CARTONOINTMENT11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
72056-030SALICYLIC ACID OINTMENT [SYNTENZA PHARMACEUTICALS LLC]1Legacy NDC, 2 package rows20181018_bafb22dd-a1cb-4cc9-ace0-549735e8aa0a.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
72056-030-01GM - Gram72056-030831f484d-5922-4e05-973e-f697deac504512019-05-02

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 2 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
72056-03072056-030-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Name, UNII, Kind table
NameUNIIKind
SALICYLIC ACIDO414PZ4LPZACTIB
Benzoic Acid8SKN0B0MIMIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
45239dbc-7282-4235-8cfb-41a286ceabb0bafb22dd-a1cb-4cc9-ace0-549735e8aa0a2018-10-16Adverse reactionsExact identifier
spl id: 45239dbc-7282-4235-8cfb-41a286ceabb0
spl set id: bafb22dd-a1cb-4cc9-ace0-549735e8aa0a

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.